Pharmaceutical

Merck and ICR enter renewed cancer drug discovery partnership

Merck KGaA and the ICR have entered into a renewed strategic collaboration to discover and develop new therapeutics for treating cancer.

Sep 25, 2023 - 20:00
Merck and ICR enter renewed cancer drug discovery partnership
Merck KGaA and the ICR have entered into a renewed strategic collaboration to discover and develop new therapeutics for treating cancer.
Read the original article

Tags:

Previous Article

Valneva receives JE vaccine supply contract from US DoD

Next Article

Boehringer and Lilly gain FDA approval for kidney disease therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

In absence of Roe v. Wade, an abortion doctor dwells on all the patients she does not see

In absence of Roe v. Wade, an abortion doctor dwells on...

Jun 24, 2023

QBiotics wins FDA orphan status for rainforest-derived cancer drug

QBiotics wins FDA orphan status for rainforest-derived ...

Feb 16, 2024

STAT+: Dexcom CEO on strategy for bringing continuous glucose monitoring to type 2 diabetes patients

STAT+: Dexcom CEO on strategy for bringing continuous g...

Jul 4, 2023